Private equity major, Advent in December 2022 had taken a majority control in Suven Pharmaceuticals (SP). At that time, Advent had disclosed in the filings that it intends to explore the merger of it’s umbrella CDMO entity, Cohance Lifesciences into SP and hence create an integrated, larger and listed franchise with the associated benefits. Now, … Read more
A view of the Lok Sabha proceedings during the winter session of Parliament. Patient groups, healthcare providers, and manufacturers associations have expressed their dismay as the Centre prepares to table the New Drugs, Cosmetics and Medical Device Bill, 2023 in Parliament, without adequately addressing their concerns, the concerned groups said in a statement | Photo … Read more
Eris is acquiring Dermatology and Nephrology branded formulations business units of Biocon Biologics (BBL), a subsidiary of Biocon Limited. The transaction is a Slump Sale Revenues of the acquired businesses for FY 2022-23 was Rs. 90 Cr and Net Worth was Rs. 25 Cr as at March 31, 2023 Transaction value is Rs 366 cr, … Read more
Scientists have found that highly abundant naturally occurring plant-based polyphenols or PPs (type of compounds) — like tannic acid found in twigs of trees like Chestnut and Oak — can help create cost-effective strategy for combating Alzheimer’s disease (AD) and reduce the societal burden of this debilitating neurodegenerative disorder. The findings are part of a … Read more
Indian Medical Association (IMA) president Dr Sharad Agarwal has raised concerns over the quality of generic medicine made in India. In an interview, he also raised concerns on restrictions placed on doctors attending medical conferences, saying educational conferences are only a discussion forum about advancements in medicine. His remarks come amid a controversy on a … Read more
With the pandemic in the rearview mirror, Wall Street has mixed views on the prospects of COVID-19 vaccine makers, as the group, once the favorite among investors, is grappling with a steep decline in sales amid falling infections. The FDA-Authorized COVID-19 makers in the U.S., Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX), Moderna (NASDAQ:MRNA), and Novavax (NASDAQ:NVAX), have … Read more